Know Cancer

or
forgot password

An Epidemiological, Non-interventional Study to Evaluate Patient Compliance in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer


N/A
18 Years
N/A
Open (Enrolling)
Female
Hormon Receptor Positive Breast Cancer

Thank you

Trial Information

An Epidemiological, Non-interventional Study to Evaluate Patient Compliance in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer


Inclusion Criteria:



- Postmenopausal females with estrogen receptor positive breast cancer that are
currently treated with aromatase inhibitor (AI) medication

- Provision of subject informed consent

Exclusion Criteria:

- If participating in any clinical trial, the subject cannot take part in this study.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Outcome Measure:

Evaluate compliance rate, as assessed by investigator, after 12 months from baseline.

Outcome Time Frame:

12 months

Safety Issue:

No

Principal Investigator

Dr Jasna Pesic

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D.spec of oncology, Institute for oncology Vojvodina, Sremska Kamenica

Authority:

Serbia: Ethics Committee

Study ID:

NIS-ORS-DUM-2010/1

NCT ID:

NCT01208779

Start Date:

January 2011

Completion Date:

March 2012

Related Keywords:

  • Hormon Receptor Positive Breast Cancer
  • Compliance
  • HR+ breast cancer
  • epidemiology
  • Breast Neoplasms

Name

Location